Free Trial

MetLife (MET) to Release Quarterly Earnings on Wednesday

MetLife logo with Finance background

MetLife (NYSE:MET - Get Free Report) is set to release its earnings data after the market closes on Wednesday, October 30th. Analysts expect MetLife to post earnings of $2.23 per share for the quarter. Persons that are interested in participating in the company's earnings conference call can do so using this link.

MetLife (NYSE:MET - Get Free Report) last announced its earnings results on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.13 by $0.15. MetLife had a return on equity of 21.41% and a net margin of 4.23%. The firm had revenue of $17.82 billion during the quarter, compared to analyst estimates of $18.57 billion. During the same quarter in the prior year, the company earned $1.94 EPS. The business's revenue was up 7.2% compared to the same quarter last year. On average, analysts expect MetLife to post $9 EPS for the current fiscal year and $10 EPS for the next fiscal year.

MetLife Stock Down 0.1 %

Shares of NYSE:MET opened at $84.77 on Wednesday. MetLife has a 52-week low of $57.91 and a 52-week high of $86.94. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.16 and a current ratio of 0.16. The firm has a market capitalization of $60.28 billion, a P/E ratio of 29.13, a P/E/G ratio of 0.69 and a beta of 1.04. The stock has a 50 day moving average price of $79.11 and a 200-day moving average price of $74.29.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be given a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 2.57%. The ex-dividend date is Tuesday, November 5th. MetLife's dividend payout ratio (DPR) is presently 74.91%.

Wall Street Analysts Forecast Growth

MET has been the subject of a number of analyst reports. Bank of America reduced their price objective on MetLife from $99.00 to $96.00 and set a "buy" rating for the company in a research report on Thursday, August 1st. Keefe, Bruyette & Woods reduced their target price on MetLife from $86.00 to $85.00 and set an "outperform" rating for the company in a report on Monday, July 8th. TD Cowen started coverage on MetLife in a report on Wednesday, October 9th. They issued a "buy" rating and a $97.00 target price for the company. JPMorgan Chase & Co. lifted their target price on MetLife from $81.00 to $86.00 and gave the stock an "overweight" rating in a report on Tuesday, July 2nd. Finally, Barclays started coverage on MetLife in a report on Wednesday, September 4th. They issued an "overweight" rating and a $91.00 target price for the company. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, MetLife currently has an average rating of "Moderate Buy" and a consensus price target of $88.46.

View Our Latest Analysis on MetLife

About MetLife

(Get Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Earnings History for MetLife (NYSE:MET)

Should you invest $1,000 in MetLife right now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?
Build-to-Order: The Strategy Fueling Toll Brothers’ Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines